Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Equity Ratio: 2019-2021

  • Bright Minds Biosciences' Equity Ratio was N/A to 0.99 in Q2 2021 from the same period last year, while for Jun 2021 it was 0.99, marking a year-over-year change of. This contributed to the annual value of 5.39 for FY2020, which is 89.27% down from last year.
  • Bright Minds Biosciences' Equity Ratio amounted to 0.99 in Q2 2021, which was down 81.62% from 5.39 recorded in Q3 2020.
  • In the past 5 years, Bright Minds Biosciences' Equity Ratio ranged from a high of 50.24 in Q3 2019 and a low of 0.99 during Q2 2021.
  • In the last 3 years, Bright Minds Biosciences' Equity Ratio had a median value of 5.39 in 2020 and averaged 18.87.
  • Data for Bright Minds Biosciences' Equity Ratio shows a maximum YoY crashed of 89.27% (in 2020) over the last 5 years.
  • Over the past 3 years, Bright Minds Biosciences' Equity Ratio (Quarterly) stood at 50.24 in 2019, then slumped by 89.27% to 5.39 in 2020, then reached 0.99 in 2021.
  • Its last three reported values are 0.99 in Q2 2021, 5.39 for Q3 2020, and 50.24 during Q3 2019.